Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:01 PM
Ignite Modification Date:
2025-12-24 @ 10:01 PM
NCT ID:
NCT01239732
Eligibility Criteria:
Inclusion Criteria:
* Histologically confirmed epithelial ovarian carcinoma, fallopian tube carcinoma, primary peritoneal carcinoma or clear cell carcinoma or carcinosarcoma. Participants with recurrent ovarian cancer who have been previously treated with surgery alone for their early stage disease are eligible.
* Eastern Cooperative Oncology Group Performance Status (ECOG PS) of 0, 1 or 2
* Life expectancy greater than or equal to (\>=3) months
Exclusion Criteria:
* Participants with non-epithelial ovarian cancer, ovarian tumors with low malignant potential (i.e., borderline tumors), or synchronous primary endometrial carcinoma
* Previous systemic therapy for ovarian cancer. Prior neo-adjuvant chemotherapy is allowed
* Planned intraperitoneal cytotoxic chemotherapy
* Radiotherapy within 28 days of Day 1, Cycle 1
* Major surgical procedure, open biopsy or significant traumatic injury within 28 days prior to first dose of Avastin
* History or evidence of National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) Grade \>=1 arterial thromboembolic event or Grade \>=3 venous thromboembolic event within 6 months prior to enrollment
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT01239732
Study Brief:
Protocol Section:
NCT01239732